Project scope
Support may relate to pharmaceutical studies, medical device clinical investigations, combination products, and selected diagnostic-related projects in Germany.
Study Start-Up support in Germany
Effective study start-up is not only administrative. It requires structured follow-up, practical coordination, and local understanding of what delays activation and what keeps timelines moving.
- Feasibility support
- Investigator and site identification
- Site selection
- Site qualification visits
- Essential document collection
- Submission package preparation
- Budget support
- Contract negotiation support
- Start-up tracking through activation
Why Study Startup Germany support matters
Study timelines are often affected by incomplete documentation, slow site follow-up, fragmented communication, and country-specific requirements. Senior local support helps reduce these bottlenecks and improves operational control during start-up.
Regulatory submission coordination
- Competent authority submissions for BfArM and PEI
- Ethics committee documentation and communication
- Radiation authority (BfS) coordination when applicable
- BOPST-related documentation where required
- Timelines aligned with EU CTR and local approval dependencies
Operational focus
The objective is not only document preparation, but practical progress toward site activation. That includes structured communication with sites, follow-up on open items, coordination of key start-up activities, and support where timelines are at risk.
Deliverables
Submission-ready packages, follow-up logs, local trackers, approval coordination, and activation-focused start-up documentation.
Connected support
Study start-up can be combined with CRA monitoring, ethics support, and regulatory affairs activities for better continuity.
Need Study Startup Germany support?
Please send your timeline, study scope, and operational priorities.